| Name | topoisomerase (DNA) II beta 180kDa |
| Description | This gene encodes a DNA topoisomerase, an enzyme that controls and alters the topologic states of DNA during transcription. This nuclear enzyme is involved in processes such as chromosome condensation, chromatid separation, and the relief of torsional stress that occurs during DNA transcription and replication. It catalyzes the transient breaking and rejoining of two strands of duplex DNA which allows the strands to pass through one another, thus altering the topology of DNA. Two forms of this enzyme exist as likely products of a gene duplication event. The gene encoding this form, beta, is localized to chromosome 3 and the alpha form is localized to chromosome 17. The gene encoding this enzyme functions as the target for several anticancer agents and a variety of mutations in this gene have been associated with the development of drug resistance. Reduced activity of this enzyme may also play a role in ataxia-telangiectasia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nHuman topoisomerase IIβ (TOP2B) plays a pivotal role in modulating DNA topology during transcription. It facilitates rapid, signal‐dependent gene activation by generating transient double‐stranded DNA breaks that promote local chromatin remodeling and permit nuclear receptor–mediated transcription. In doing so, TOP2B interacts with multifunctional transcription factors and cofactors—such as retinoic acid receptor α, nuclear respiratory factor 1 and the SWI/SNF complex—to coordinate the formation and repair of these breaks, thereby linking DNA damage–response pathways to regulated gene expression. This catalytic function is central not only to relieving torsional stress during transcription but also to ensuring appropriate promoter clearance and transcript elongation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "8"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nDistinct from its closely related isoform TOP2A, which is critical for cell proliferation, TOP2B is dispensable for cell division yet essential in post‐mitotic contexts such as neuronal development and differentiation. Its expression is dynamically regulated in differentiating cells and appears to influence the transcription of long neural genes. Moreover, studies show that TOP2B’s nuclear localization and mobility are tightly controlled—features that likely underpin its role in developmental gene regulation and maintenance of genomic stability during lineage commitment."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "9", "end_ref": "16"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its developmental roles, TOP2B is a critical determinant of cellular responses to chemotherapeutic agents and other genotoxic stresses. It is targeted by topoisomerase poisons that induce covalent TOP2B–DNA cleavage complexes—events implicated in treatment‐related secondary malignancies and drug‐induced cardiotoxicity—and its natural amino acid variants can modulate cellular sensitivity to such drugs. Furthermore, TOP2B function is influenced by post‐translational modifications and interactions with kinases (for example, PKCζ), which alter its catalytic activity and stability, while its involvement in viral genome maintenance and innate immune responses further underscores its multifaceted regulatory significance. Structural studies have provided detailed insights into the ATPase domain of TOP2B, reinforcing its importance as a therapeutic target."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "17", "end_ref": "39"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Hai Xiao, Yong Mao, Shyamal D Desai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The topoisomerase IIbeta circular clamp arrests transcription and signals a 26S proteasome pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0736401100"}], "href": "https://doi.org/10.1073/pnas.0736401100"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12629207"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12629207"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Bong-Gun Ju, Victoria V Lunyak, Valentina Perissi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.1127196"}], "href": "https://doi.org/10.1126/science.1127196"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16794079"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16794079"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Suzan McNamara, Hongling Wang, Nessrine Hanna, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Topoisomerase IIbeta negatively modulates retinoic acid receptor alpha function: a novel mechanism of retinoic acid resistance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.01576-07"}], "href": "https://doi.org/10.1128/MCB.01576-07"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18212063"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18212063"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Mohammad B Hossain, Ping Ji, Ramakrishnan Anish, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Poly(ADP-ribose) Polymerase 1 Interacts with Nuclear Respiratory Factor 1 (NRF-1) and Plays a Role in NRF-1 Transcriptional Regulation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M807198200"}], "href": "https://doi.org/10.1074/jbc.M807198200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19181665"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19181665"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Kevin W Trotter, Heather A King, Trevor K Archer "}, {"type": "b", "children": [{"type": "t", "text": "Glucocorticoid Receptor Transcriptional Activation via the BRG1-Dependent Recruitment of TOP2β and Ku70/86."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.00230-15"}], "href": "https://doi.org/10.1128/MCB.00230-15"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26055322"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26055322"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Liis Uusküla-Reimand, Huayun Hou, Payman Samavarchi-Tehrani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Topoisomerase II beta interacts with cohesin and CTCF at topological domain borders."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genome Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13059-016-1043-8"}], "href": "https://doi.org/10.1186/s13059-016-1043-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27582050"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27582050"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Lori Broderick, Shawn Yost, Dong Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in topoisomerase IIβ result in a B cell immunodeficiency."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-019-11570-6"}], "href": "https://doi.org/10.1038/s41467-019-11570-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31409799"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31409799"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Heeyoun Bunch, Jaehyeon Jeong, Keunsoo Kang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "BRCA1-BARD1 regulates transcription through modulating topoisomerase IIβ."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Open Biol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1098/rsob.210221"}], "href": "https://doi.org/10.1098/rsob.210221"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34610268"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34610268"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Morten O Christensen, Morten K Larsen, Hans Ullrich Barthelmes, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dynamics of human DNA topoisomerases IIalpha and IIbeta in living cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1083/jcb.200112023"}], "href": "https://doi.org/10.1083/jcb.200112023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11927602"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11927602"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Chun-Nam Lok, Alexander J Lang, Shelagh E L Mirski, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BJ20020791"}], "href": "https://doi.org/10.1042/BJ20020791"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12197834"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12197834"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Shelagh E L Mirski, Juliane C Bielawski, Susan P C Cole "}, {"type": "b", "children": [{"type": "t", "text": "Identification of functional nuclear export sequences in human topoisomerase IIalpha and beta."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0006-291x(03)01077-5"}], "href": "https://doi.org/10.1016/s0006-291x(03"}, {"type": "t", "text": "01077-5) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12821127"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12821127"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Anand K Kondapi, Nathamu Satyanarayana, A D Saikrishna "}, {"type": "b", "children": [{"type": "t", "text": "A study of the topoisomerase II activity in HIV-1 replication using the ferrocene derivatives as probes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Biochem Biophys (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.abb.2006.04.003"}], "href": "https://doi.org/10.1016/j.abb.2006.04.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16712776"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16712776"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Xin Heng, Wei-Dong Le "}, {"type": "b", "children": [{"type": "t", "text": "The function of DNA topoisomerase IIβ in neuronal development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurosci Bull (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12264-010-0625-9"}], "href": "https://doi.org/10.1007/s12264-010-0625-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20882068"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20882068"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Sevim Isik, Merve Zaim, Mehmet Taha Yildiz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "DNA topoisomerase IIβ as a molecular switch in neural differentiation of mesenchymal stem cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Hematol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00277-014-2209-7"}], "href": "https://doi.org/10.1007/s00277-014-2209-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25217229"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25217229"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Lauren F Harkin, Dianne Gerrelli, Diana C Gold Diaz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Distinct expression patterns for type II topoisomerases IIA and IIB in the early foetal human telencephalon."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Anat (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/joa.12416"}], "href": "https://doi.org/10.1111/joa.12416"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26612825"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26612825"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "V Satish Bollimpelli, Pankaj S Dholaniya, Anand K Kondapi "}, {"type": "b", "children": [{"type": "t", "text": "Topoisomerase IIβ and its role in different biological contexts."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Biochem Biophys (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.abb.2017.06.021"}], "href": "https://doi.org/10.1016/j.abb.2017.06.021"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28669856"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28669856"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Isabelle Plo, Hélène Hernandez, Glenda Kohlhagen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of the atypical protein kinase C zeta reduces topoisomerase II catalytic activity, cleavable complexes formation, and drug-induced cytotoxicity in monocytic U937 leukemia cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M204654200"}], "href": "https://doi.org/10.1074/jbc.M204654200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12105221"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12105221"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Jacira M A De Sousa, Susan M Lareau, Richard D Pearson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of Leishmania chagasi DNA topoisomerase II: a potential chemotherapeutic target."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Scand J Infect Dis (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/00365540310017023"}], "href": "https://doi.org/10.1080/00365540310017023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14723357"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14723357"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Christian Mielke, Morten O Christensen, Hans Ullrich Barthelmes, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Enhanced processing of UVA-irradiated DNA by human topoisomerase II in living cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.C400032200"}], "href": "https://doi.org/10.1074/jbc.C400032200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15044480"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15044480"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Yuko Yonezawa, Tsuyoshi Tsuzuki, Takahiro Eitsuka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibitory effect of conjugated eicosapentaenoic acid on human DNA topoisomerases I and II."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Biochem Biophys (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.abb.2004.12.011"}], "href": "https://doi.org/10.1016/j.abb.2004.12.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15680922"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15680922"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Anand K Kondapi, Gade Padmaja, N Satyanarayana, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A biochemical analysis of topoisomerase II alpha and beta kinase activity found in HIV-1 infected cells and virus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Biochem Biophys (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.abb.2005.06.021"}], "href": "https://doi.org/10.1016/j.abb.2005.06.021"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16091284"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16091284"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Kyeongmee Park, Sehwan Han, Geum-Hee Gwak, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Topoisomerase II-alpha gene deletion is not frequent as its amplification in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Breast Cancer Res Treat (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10549-006-9170-7"}], "href": "https://doi.org/10.1007/s10549-006-9170-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16502015"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16502015"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "K Chikamori, J E Hill, D R Grabowski, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of topoisomerase IIbeta in myeloid leukemia cell lines leads to activation of apoptosis following all-trans retinoic acid-induced differentiation/growth arrest."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Leukemia (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.leu.2404351"}], "href": "https://doi.org/10.1038/sj.leu.2404351"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16932348"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16932348"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Wing-Pui Tsang, Siu-Kai Kong, Tim-Tak Kwok "}, {"type": "b", "children": [{"type": "t", "text": "Epidermal growth factor induction of resistance to topoisomerase II toxins in human squamous carcinoma A431 cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2006)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16969495"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16969495"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Shelagh E L Mirski, Kathryn E Sparks, Beate Friedrich, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Topoisomerase II binds importin alpha isoforms and exportin/CRM1 but does not shuttle between the nucleus and cytoplasm in proliferating cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Cell Res (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yexcr.2006.11.004"}], "href": "https://doi.org/10.1016/j.yexcr.2006.11.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17182034"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17182034"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Toshio Uesaka, Tadahisa Shono, Daisuke Kuga, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Enhanced expression of DNA topoisomerase II genes in human medulloblastoma and its possible association with etoposide sensitivity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurooncol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11060-007-9360-0"}], "href": "https://doi.org/10.1007/s11060-007-9360-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17361331"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17361331"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Inna G Ovsyannikova, Neelam Dhiman, Iana H Haralambieva, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Genet (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00439-009-0763-1"}], "href": "https://doi.org/10.1007/s00439-009-0763-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19902255"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19902255"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Bin Zhang, Mo Liu, Hai-kuo Tang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The expression and significance of MRP1, LRP, TOPOIIβ, and BCL2 in tongue squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Oral Pathol Med (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1600-0714.2011.01066.x"}], "href": "https://doi.org/10.1111/j.1600-0714.2011.01066.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21793937"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21793937"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "David L Hermanson, Sonia G Das, Yunfang Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of Mcl-1 confers multidrug resistance, whereas topoisomerase IIβ downregulation introduces mitoxantrone-specific drug resistance in acute myeloid leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Pharmacol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/mol.113.086140"}], "href": "https://doi.org/10.1124/mol.113.086140"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23696245"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23696245"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Yi Ban, Chia-Wen Ho, Ren-Kuo Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Activation of a novel ubiquitin-independent proteasome pathway when RNA polymerase II encounters a protein roadblock."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.00403-13"}], "href": "https://doi.org/10.1128/MCB.00403-13"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23938298"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23938298"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Ming Geng, Lin Wang, Xin Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The association between chemosensitivity and Pgp, GST-π and Topo II expression in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diagn Pathol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1746-1596-8-198"}], "href": "https://doi.org/10.1186/1746-1596-8-198"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24326092"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24326092"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Nicholas A Smith, Jo Ann W Byl, Susan L Mercer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Etoposide quinone is a covalent poison of human topoisomerase IIβ."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/bi500421q"}], "href": "https://doi.org/10.1021/bi500421q"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24766193"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24766193"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Margaret Tarrant-Elorza, Cyprian C Rossetto, Gregory S Pari "}, {"type": "b", "children": [{"type": "t", "text": "Maintenance and replication of the human cytomegalovirus genome during latency."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Host Microbe (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.chom.2014.06.006"}], "href": "https://doi.org/10.1016/j.chom.2014.06.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25011107"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25011107"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Christian Henninger, Gerhard Fritz "}, {"type": "b", "children": [{"type": "t", "text": "Statins in anthracycline-induced cardiotoxicity: Rac and Rho, and the heartbreakers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2016.418"}], "href": "https://doi.org/10.1038/cddis.2016.418"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28102848"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28102848"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Toshiyuki Kozuki, Kenichi Chikamori, Marius D Surleac, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nucleic Acids Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/nar/gkx325"}], "href": "https://doi.org/10.1093/nar/gkx325"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28472494"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28472494"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Stefan Zdraljevic, Christine Strand, Hannah S Seidel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Natural variation in a single amino acid substitution underlies physiological responses to topoisomerase II poisons."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Genet (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pgen.1006891"}], "href": "https://doi.org/10.1371/journal.pgen.1006891"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28700616"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28700616"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Talita Diniz Melo-Hanchuk, Priscila Ferreira Slepicka, Alessandra Luiza Pelegrini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NEK5 interacts with topoisomerase IIβ and is involved in the DNA damage response induced by etoposide."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.28943"}], "href": "https://doi.org/10.1002/jcb.28943"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31090963"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31090963"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Ning Cui, Fujian Wu, Wen-Jing Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Doxorubicin-induced cardiotoxicity is maturation dependent due to the shift from topoisomerase IIα to IIβ in human stem cell derived cardiomyocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.14346"}], "href": "https://doi.org/10.1111/jcmm.14346"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31106979"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31106979"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Elise M Ling, Arnaud Baslé, Ian G Cowell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A comprehensive structural analysis of the ATPase domain of human DNA topoisomerase II beta bound to AMPPNP, ADP, and the bisdioxopiperazine, ICRF193."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Structure (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.str.2022.05.009"}], "href": "https://doi.org/10.1016/j.str.2022.05.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35660158"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35660158"}]}]}]}
|
| Synonyms | TOPIIB, TOP2BETA |
| Proteins | TOP2B_HUMAN |
| NCBI Gene ID | 7155 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
TOP2B has 10,505 functional associations with biological entities spanning 9 categories (molecular profile, organism, functional term, phrase or reference, chemical, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 134 datasets.
Click the + buttons to view associations for TOP2B from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of TOP2B gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of TOP2B gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TOP2B gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of TOP2B gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of TOP2B gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of TOP2B gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| Biocarta Pathways | pathways involving TOP2B protein from the Biocarta Pathways dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of TOP2B gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TOP2B gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TOP2B gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of TOP2B gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of TOP2B gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of TOP2B gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene Mutation Profiles | cell lines with TOP2B gene mutations from the CCLE Cell Line Gene Mutation Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with TOP2B protein from the CCLE Cell Line Proteomics dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of TOP2B gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of TOP2B gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of TOP2B gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with TOP2B gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CM4AI U2OS Cell Map Protein Localization Assemblies | assemblies containing TOP2B protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TOP2B gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing TOP2B protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing TOP2B protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores | cellular components containing TOP2B protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with TOP2B protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with TOP2B protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| CORUM Protein Complexes | protein complexs containing TOP2B protein from the CORUM Protein Complexes dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of TOP2B gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with TOP2B gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with TOP2B gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with TOP2B gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with TOP2B gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of TOP2B protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by TOP2B gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores | diseases associated with TOP2B gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with TOP2B gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with TOP2B gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with TOP2B gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with TOP2B gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with TOP2B gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for TOP2B protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at TOP2B gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of TOP2B gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of TOP2B gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing TOP2B from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with TOP2B gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with TOP2B gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of TOP2B gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with TOP2B gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing TOP2B from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of TOP2B gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of TOP2B gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of TOP2B gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TOP2B gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of TOP2B gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of TOP2B gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving TOP2B gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving TOP2B gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving TOP2B gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing TOP2B protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing TOP2B protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing TOP2B protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by TOP2B gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of TOP2B gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of TOP2B gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of TOP2B gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TOP2B gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of TOP2B gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with TOP2B gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of TOP2B gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for TOP2B protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of TOP2B gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of TOP2B gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of TOP2B protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TOP2B gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HPM Cell Type and Tissue Protein Expression Profiles | cell types and tissues with high or low expression of TOP2B protein relative to other cell types and tissues from the HPM Cell Type and Tissue Protein Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for TOP2B from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with TOP2B gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by TOP2B gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for TOP2B protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of TOP2B gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of TOP2B gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of TOP2B gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEA Substrates of Kinases | kinases that phosphorylate TOP2B protein from the curated KEA Substrates of Kinases dataset. | |
| Kinase Library Serine Threonine Kinome Atlas | kinases that phosphorylate TOP2B protein from the Kinase Library Serine Threonine Atlas dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of TOP2B gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of TOP2B gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with TOP2B gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of TOP2B gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of TOP2B gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of TOP2B gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TOP2B gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing TOP2B protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain TOP2B protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by TOP2B gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting TOP2B gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of TOP2B gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by TOP2B gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Cancer Gene Co-expression Modules | co-expressed genes for TOP2B from the MSigDB Cancer Gene Co-expression Modules dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of TOP2B gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of TOP2B gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| NURSA Protein Complexes | protein complexs containing TOP2B protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| PANTHER Pathways | pathways involving TOP2B protein from the PANTHER Pathways dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for TOP2B from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of TOP2B gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of TOP2B gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving TOP2B protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving TOP2B protein from the Wikipathways PFOCR 2024 dataset. | |
| Phosphosite Textmining Biological Term Annotations | biological terms co-occuring with TOP2B protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset. | |
| PhosphoSitePlus Substrates of Kinases | kinases that phosphorylate TOP2B protein from the curated PhosphoSitePlus Substrates of Kinases dataset. | |
| ProteomicsDB Cell Type and Tissue Protein Expression Profiles | cell types and tissues with high or low expression of TOP2B protein relative to other cell types and tissues from the ProteomicsDB Cell Type and Tissue Protein Expression Profiles dataset. | |
| Reactome Pathways 2024 | pathways involving TOP2B protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of TOP2B gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of TOP2B gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of TOP2B gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of TOP2B gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TOP2B gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at TOP2B gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of TOP2B gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of TOP2B gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with TOP2B protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of TOP2B gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs | drug perturbations changing phosphorylation of TOP2B protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs dataset. | |
| SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands | ligand (protein) perturbations changing phosphorylation of TOP2B protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of TOP2B gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of TOP2B gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of TOP2B gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of TOP2B gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of TOP2B protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of TOP2B protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of TOP2B protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of TOP2B protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with TOP2B protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with TOP2B protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |